Susan Hauser
Impact in
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
Papers in
- Surgery 14
- Cholesterol and Lipid Metabolism 13
- Pediatric Hepatobiliary Diseases and Treatments 2
-
- Protein Hydrolysis and Bioactive Peptides 4
- Peroxisome Proliferator-Activated Receptors 3
- Co-authors
- Sarah Shefer (15 shared papers)Erwin H. Mosbach (4 shared papers)E.H. Mosbach (6 shared papers)Ihor Bekersky (2 shared papers)A K Batta (4 shared papers)G Salen (3 shared papers)Gerald Salen (3 shared papers)G. Stephen Tint (1 shared paper)
- Journals
- Journal of Lipid Research (10 papers)Journal of Biological Chemistry (3 papers)Journal of Clinical Investigation (2 papers)Metabolism (2 papers)PubMed (1 paper)
- Partner nations
- United States
In The Last Decade
Susan Hauser
18 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 69
- Pharmacology 333
- Oncology 644
- Clinical Biochemistry 139
- Endocrinology, Diabetes and Metabolism 313
- Surgery 819
Countries citing papers authored by Susan Hauser
This map shows the geographic impact of Susan Hauser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Hauser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Hauser more than expected).
Fields of papers citing papers by Susan Hauser
This network shows the impact of papers produced by Susan Hauser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Hauser. The network helps show where Susan Hauser may publish in the future.
Co-authors
The 25 scholars most cited alongside Susan Hauser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1968 | 221 | |
| 2 | 1970 | 219 | |
| 3 | 1969 | 190 | |
| 4 | 1973 | 186 | |
| 5 | 1972 | 125 | |
| 6 | 1988 | 75 | |
| 7 | 1973 | 67 | |
| 8 | 1981 | 57 | |
| 9 | 1972 | 53 | |
| 10 | 1972 | 49 | |
| 11 | 1982 | 37 | |
| 12 | 1966 | 35 | |
| 13 | 1966 | 27 | |
| 14 | 1991 | 26 | |
| 15 | 1984 | 23 | |
| 16 | 1997 | 19 | |
| 17 | 1994 | 3 | |
| 18 | [Neytumorin as biomodular onco-therapy--allegations without documentation]. | 1997 | 1 |
About Susan Hauser
Susan Hauser is a scholar working on Surgery, Molecular Biology, Oncology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (13 papers), Drug Transport and Resistance Mechanisms (8 papers), Pharmacogenetics and Drug Metabolism (6 papers), Protein Hydrolysis and Bioactive Peptides (4 papers), Peroxisome Proliferator-Activated Receptors (3 papers), Cancer, Lipids, and Metabolism (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (2 papers). The work is most often cited by research in Pharmacology (333 citations), Oncology (644 citations), Clinical Biochemistry (139 citations), Endocrinology, Diabetes and Metabolism (313 citations) and Surgery (819 citations). Susan Hauser has collaborated with scholars based in United States. Frequent co-authors include Sarah Shefer, Erwin H. Mosbach, E.H. Mosbach, Ihor Bekersky, A K Batta, G Salen, Gerald Salen, G. Stephen Tint, F. W. Cheng and L Nguyen. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Journal of Clinical Investigation, Metabolism and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.